Pablo Sanchis: How the Bone Tumor Microenvironment Drives Osteopontin Expression in Metastatic Prostate Cancer
Pablo Sanchis, Postdoctoral Intern at MD Anderson Cancer Center, shared a post on X he and colleagues co-authored:
“Check out our work Oncogene unveiling how the bone TME drives Osteopontin expression in metastatic prostate cancer and its association with resistance to AR signaling blockade.”
Title: PKA-driven SPP1 activation as a novel mechanism connecting the bone microenvironment to prostate cancer progression
Authors: Pablo Sanchis, Agustina Sabater, Julia Lechuga, Jimena Rada, Rocio Seniuk, Gaston Pascual, Mora Gatti, Juan Bizzotto, Peter D. A. Shepherd, Jun Yang, Javier Cotignola, Elba Vazquez, Joaquin Mateo, Pia Valacco, Estefania Labanca, Christopher Logothetis, Geraldine Gueron, Nicolas Anselmino
Read The Full Article at Oncogene.
More Posts Featuring Prostate Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023